|Education||BS, University of West Florida|
Breast cancer is one of the most common cancers mainly afflicting women. It is estimated that 1 in 8 will develop it at some point in their lives. Needless to say, better understanding leading to advancements in the clinical setting are of paramount importance. One of the major hurdles in overcoming this disease is the concept of tumor heterogeneity, because tumors are all different from each other, and even within tumors itself clonal populations can possess different mutations, we are proposing the use of circulating plasma tumor DNA as a way to identify potential biomarkers; while overcoming tumor heterogeneity.